Johnson & Johnson Form 8-K Summary
Business Context and Reporting Period
Johnson & Johnson (JNJ) filed a Current Report on Form 8-K on July 15, 2026. The filing announces the Company's sales and earnings results for the second quarter ended June 28, 2026.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained in the attached press release (Exhibit 99.1) and the Unaudited Comparative Supplementary Sales Data (Exhibit 99.2), which are referenced but not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It serves as a notification that the results have been issued and directs readers to the attached exhibits for comparative data.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. Such details are expected to be found in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2026 revenue and earnings per share figures.
- Examine Exhibit 99.2 for year-over-year growth rates and segment performance.
- Verify any updated full-year 2026 guidance provided in the press release.
- Check for any new litigation or regulatory updates mentioned in the full press release text.